title: Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulfasalazine.
authors.forename: G J
authors.initials: GJ
authors.lastname: Mantzaris
authors.forename: E
authors.initials: E
authors.lastname: Archavlis
authors.forename: C
authors.initials: C
authors.lastname: Zografos
authors.forename: K
authors.initials: K
authors.lastname: Zavos
authors.forename: K
authors.initials: K
authors.lastname: Petraki
authors.forename: G
authors.initials: G
authors.lastname: Triadaphyllou
mesh_terms: D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D016481:Helicobacter Infections / Q000150:complications*; D016480:Helicobacter pylori; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D012460:Sulfasalazine / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D012460:Sulfasalazine